05Y fundamentals
Vivoryon Therapeutics N.V. financial statements, including revenue, expenses, profit, and loss
The total revenue of 05Y for the last semiannual is 0.00 EUR, and it's 100.00% higher compared to the previous semiannual. The net income of H1 24 is -13.56 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM